Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2018-12-12 | New | $3,000,000 | $3,000,000 | Equity Only | 06b | SEC link |
| 2015-01-05 | New | $511,175 | $511,175 | Equity Only | 06b | SEC link |
| 2010-12-22 | Amended | $875,000 | $775,000 | Equity Only | 06 | SEC link |
| 2010-09-21 | New | $100,000 | $100,000 | Equity Only | 06 | SEC link |
| 2010-05-11 | New | $120,000 | $120,000 | Debt Only | 06 | SEC link |
| 2009-03-09 | Paper Filing | Unknown | Unknown | Other | Not Available |
| Name | Role |
|---|---|
| Joerg Baier | Director |
| Andrew De Marco | Director |
| Stanley Gembicki | Director |
| Steve Gordon | Director |
| John F. Hardin | Director |
| Lisa A Johnson | Executive |
| Kenneth U. Johnson | Director |
| Robert Mierendorf | Executive |
| Anil Oroskar | Promoter |
| Asha Oroskar | Promoter |
| Stelios Papadopoulos | Director |
| John Scheller | Director |